Track topics on Twitter Track topics that are important to you
Our value is our unrivalled ability to enable almost limitless supplies of natural bioingredients to be produced with no harmful chemicals or genetic modification. To achieve this we have developed proprietary process technologies, including biotransformation and unique separation techniques, suitable for a wide range of applications. In essence, biotransformation uses natural microorganisms and enzymes to convert a starting material into a more useful and valuable compound. Zylepsis has built an extensive library of organisms (and enzymes) that work under mild conditions, usually in water, at non-extreme temperatures. They do not use toxic chemical reagents, nor do they leave harmful residues for disposal. In addition to these already considerable advantages, biotransformation often allows complex or unusual reactions to be performed, not possible using conventional chemistry. We are able to exploit the selectivity and specificity of enzymes and organisms to control the biocatalytic process that will produce the desired ingredient.
6 Highpont, Henwood Business Estate
Phone: 01233 660 555
Fax: 01233 660 777
Oxford, UK, 1 November 2017: e-Therapeutics plc (AIM: ETX), a company pioneering the use of Network-Driven Drug Discovery (NDD) to create new and better drugs, announces the appointment of Christine...
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
MELBOURNE, Australia, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the developmen...
MosaiQ project de-risked, Verification and Validation (“V&V”) “head-to-head” studies confirm targeted concordance levels for all blood grouping assaysEuropean field trials planned to co...
JERSEY, Channel Islands, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Execut...
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
MELBOURNE, Australia, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development of diagn...
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
Our value is our unrivalled ability to enable almost limitless supplies of natural bioingredients to be produced with no harmful chemicals or genetic modification. To achieve this we have developed pr...
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...
We have published hundreds of Zylepsis Limited news stories on BioPortfolio along with dozens of Zylepsis Limited Clinical Trials and PubMed Articles about Zylepsis Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zylepsis Limited Companies in our database. You can also find out about relevant Zylepsis Limited Drugs and Medications on this site too.